Transcripts

Biomarin Pharmaceutical (BMRN) earnings call transcripts

Every Biomarin Pharmaceutical Inc. earnings call Gloomberb has transcribed, with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed Amicus as exceeding integration expectations while competitive pressure on Voxzogo remains manageable and pipeline execution accelerates.

    Aug 06, 2026Confident0.84